PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

2402, 2017

Caterina De Luca et al., KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test. CytoJournal

2202, 2017

Alessia Nottegar et al., Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis. Experimental and Molecular Pathology

3101, 2017

Daniela Furlan et al., Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis. British Journal of Cancer

2301, 2017

Elisabetta Macerola et al., BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report

2301, 2017

Giulia Morosetti et al., Ellagic acid and Annona muricata in the chemoprevention of HPV-related pre-neoplastic lesions of the cervix. Oncology Letters

2101, 2017

Egesta Lopci et al., Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. European Journal of Nuclear Medicine and Molecular Imaging

101, 2017

Elisabetta Macerola et al., BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report. International Journal of Surgical Pathology

2312, 2016

Luca Reggiani Bonetti et al., Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer

1312, 2016

Chiara Cremolini et al., Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest. European Journal of Cancer

812, 2016

Beth O. Van Emburgh et al., Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nature Communications

2711, 2016

Adriana Romiti et al., The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs

2511, 2016

Laura Capelli et al., No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Scientific Reports

Previous 252627 Next